Remove 2024 Remove Biotechnology Remove Contract research organization
article thumbnail

Top 10 Strategic Imperatives Driving Innovation in AI-Enhanced Drug Discovery and Development

Frost & Sullivan

growth from 2023 to 2024. This is fueling the growing demand for outsourcing, with contract research organizations (CROs) and contract development and manufacturing organizations (CDMOs) driving industry growth. However, the pharma/biopharma industry overall shows stagnant R&D activity.

article thumbnail

Clinion Applauded by Frost & Sullivan for Enabling Interoperability and Continuity in Clinical Trials Management with its eClinical Solutions

Frost & Sullivan

July 9, 2024 – Frost & Sullivan recently assessed the integrated clinical trial optimization industry and, based on its findings, recognizes Clinion with the 2024 North American Technology Innovation Leadership Award. SAN ANTONIO, TX. The company is an innovator in the clinical trial and data management space.

article thumbnail

Southern Star Research Applauded by Frost & Sullivan for Delivering Comprehensive Clinical Trial Solutions and Its Competitive Strategies

Frost & Sullivan

13 th February 2025 Frost & Sullivan recently analyzed the biotechnology contract research organization (CRO) industry and, based on its findings, recognizes Southern Star Research with the 2024 Asia-Pacific Competitive Strategy Leadership Award. SAN ANTONIO, TX.

Biotech 52